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Available online 6 February 2016Pseudomonas aeruginosa is an opportunistic pathogen that induces severe lung infections such as ventilator-
associated pneumonia and acute lung injury. Under these conditions, the bacterium diminishes epithelial integ-
rity and inhibits tissue repair mechanisms, leading to persistent infections. Understanding the involved bacterial
virulence factors and their mode of action is essential for the development of new therapeutic approaches.
In our study we discovered a so far unknown effect of the P. aeruginosa lectin LecB on host cell physiology. LecB
alone was sufﬁcient to attenuate migration and proliferation of human lung epithelial cells and to induce tran-
scriptional activity of NF-κB. These effects are characteristic of impaired tissue repair. Moreover, we found a
strong degradation of β-catenin, which was partially recovered by the proteasome inhibitor lactacystin. In addi-
tion, LecB induced loss of cell–cell contacts and reduced expression of the β-catenin targets c-myc and cyclin D1.
Blocking of LecB binding to host cell plasmamembrane receptors by soluble L-fucose prevented these changes in
host cell behavior and signaling, and thereby provides a powerful strategy to suppress LecB function.
Our ﬁndings suggest that P. aeruginosa employs LecB as a virulence factor to induce β-catenin degradation,which
then represses processes that are directly linked to tissue recovery.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Bacterial pathogenesis1. Introduction
Hospital-acquired infections are serious issues in human health
and therapy. One of the most common nosocomial pathogens is
Pseudomonas aeruginosa [1,2]. Infections with this bacterium result in
epithelial damage and affected tissues regenerate only slowly. For in-
stance, P. aeruginosa causes ventilator-associated pneumonia leading
to acute lung injury (ALI), which is characterized by loss of epithelial
and endothelial integrity inside the alveoli, and strong induction of in-
ﬂammation [3,4]. During normal tissue repair, inﬂammation markers
are reduced facilitating cell proliferation and proper tissue regeneration
[5]. However, upon bacterial infection, high and persistent levels of in-
ﬂammation markers (e.g. TNF-α) can undermine repair mechanisms
[6].
To date, several P. aeruginosa virulence factors are known to inﬂu-
ence host cell processes that are implicated in tissue repair [4,7]. The
P. aeruginosa lectin LecB was previously described as adhesion factority Freiburg, BIOSS Centre for
e (W. Römer).
. This is an open access article underwith a high binding afﬁnity for L-fucose and its derivatives [8]. It occurs
as a tetramer, ismainly found at the outer bacterialmembrane and is in-
volved in bioﬁlm formation [9,10]. Moreover, LecB agglutinates human
peripheral lymphocytes, decreases the ciliary beating frequency of nasal
epithelial cells and binds and stimulates follicular lymphoma cells
[11–13]. Interestingly, a LecB-deﬁcient mutant of P. aeruginosa and the
LecB-inhibition with soluble carbohydrate ligands decreased the bacte-
rial burden and dissemination in an in vivomurinemodel of ALI [14,15].
Beta-catenin signaling is critically implicated in tissue homeostasis
and repair [16–18]. As part of adherens junctions β-catenin stabilizes
cell–cell contacts by connecting cadherins to the actin cytoskeleton.
These junctional complexes can be further promoted and stabilized
through interaction with α3β1-integrins and CD151-tetraspanins [19].
In addition, β-catenin is the central player of the canonical Wnt signal-
ing, in which it translocates to the nucleus upon Wnt activation
resulting in transcriptional regulation of target genes [20,21]. Thereby,
it promotes proliferation and migration during development, tissue
homeostasis and repair [22,23]. Without stimulation of Wnt ligands,
the cytosolic β-catenin pool is continuously marked for proteasomal
degradation by a destruction complex containing GSK-3β and
Axin [20,21]. Several studies also reported a regulatory function ofthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Salmonella typhimurium or Mycobacterium tuberculosis β-catenin was
described as antagonist of NF-κB, which itself is a strong inducer of in-
ﬂammatory processes [24–26]. In an in vivo keratitis model β-catenin
degradation has also been demonstrated for P. aeruginosa infection
[27]. The thereby induced strong inﬂammation diminished recovery
and therapeutic success. However, no P. aeruginosa factors able to ma-
nipulate cellular β-catenin protein levels have been identiﬁed so far.
In this study, we show that soluble LecB caused β-catenin degrada-
tion together with attenuation of cell migration and proliferation in
lung epithelial cells. At the same time, we observed an activation of
NF-κB signaling and an increase in TNF-α expression indicating an in-
duction of inﬂammation. Based on these results we propose that LecB
has a role in disturbing cellular repair processes in order to facilitate ro-
bust and enduring colonization and infection of injured tissue.
2. Results
2.1. P. aeruginosa lectin LecB attenuates cell proliferation and migration
and activates NF-κB p65
P. aeruginosa is one of themost common pathogens found in ALI and
infected wounds [1,4]. In order to assay if LecB is sufﬁcient to inhibit
tissue repair, we initially investigated three crucial host cell processes:
migration, inﬂammation and proliferation.We chose the lung epithelial
cell line H1299 as a model system because P. aeruginosa frequently
infects lung tissue. For stimulation we used recombinantly produced,
soluble LecB.
Tomeasure themigratory activity of cellswe performed convention-
al scratch assays. We observed a pronounced decrease in migration dis-
tance and speed during LecB treatment in a dose-dependent manner,
whereas used concentrations ranged from 0.09 μM to 4.3 μM of LecB
(Fig. 1A and B). Since the inhibitory effect was most pronounced with
4.3 μM LecB, the following experiments were conducted with this
concentration. As control, co-incubation with 43 mM L-fucose was
performed in order to saturate the fucose binding sites at LecB, which,
in turn, inhibited the interaction between the lectin and host cell recep-
tors. As shown in Fig. 1A (red lines) and Fig. 1B co-incubation with
L-fucose rescued cell migration.
In order to investigate inﬂammation we focused on NF-κB signaling,
which has been described to be induced by P. aeruginosa [28]. During its
activation, NF-κB is translocated from the cytosol to the nucleus. To de-
termine nuclear translocation of NF-κB, cells were co-stained for p65,
themost common NF-κB protein in inﬂammation, and DAPI to visualize
nuclei (Fig. 1C). Mean ﬂuorescence intensity (MFI) values of p65 inside
the nuclei weremeasured to quantify nuclear translocation (Fig. 1D). As
seen in Fig. 1C andD, LecB andTNF-α, as positive control, resulted in sig-
niﬁcantly higher nuclear MFI values of p65. We also analyzed if LecB
treatment inﬂuences the phosphorylation status of p65 (Suppl. Fig. 1A
and 1B). Upon LecB treatment, phosphorylation at Ser536 was measur-
ably elevated after 30 min and continuously increased for longer treat-
ment times. Ser536 phosphorylation of p65 has been described to be
important for increased transcriptional activity and acetylation of
NF-κB p65 [29,30]. In contrast, the phosphorylation site at Ser468 was
unaffected during LecB treatment. Phosphorylation at Ser468 has been
shown to usually have suppressive effects on NF-κB activity [31]. There-
fore, the constant phosphorylation at Ser468 argues neither for nor
against an activation of p65. However, compared to TNF-α, which is
able to induce NF-κB activation within minutes [32], LecB-mediated
NF-κB responses appear to start later (after approximately 30 min,
Suppl. Fig. 1A and 1B). In order to verify if the observed phosphorylation
and nuclear translocation of p65 also results in increased transcriptional
activity, we transfected cells with a NF-κB luciferase reporter plasmid
and analyzed the resulting luciferase expression [33]. Indeed, we mea-
sured a two-fold increase of NF-κB reporter activity upon 5 h of LecB
stimulation, whereas TNF-α incubation elevated the reporter activityto a ﬁve times higher level (Fig. 1E). Again, co-incubation with LecB
and L-fucose blocked both nuclear translocation and luciferase activity
(Fig. 1C–E). Finally, we examinedwhether the increased transcriptional
activity results in an enhanced expression of NF-κB targets. To this end,
we analyzedmRNA levels of TNF-α, since it is a common target of NF-κB
and is frequently associated with delayed tissue recovery [3,6]. As
depicted in Fig. 1F, LecB stimulation continuously elevated TNF-α
mRNA levels resulting in a 20-fold induction after overnight incubation
(16 h). In the presence of L-fucose mRNA levels of TNF-α remained at
control levels (Fig. 1G).
For analysis of the proliferative activity of LecB-treated cells, we
quantiﬁed the incorporation of a thymidine derivative (EdU), which en-
ables to determine DNA synthesis during proliferation. EdUwas labeled
with Alexa488 for confocal ﬂuorescence microscopy andwith Alexa647
for FACS analysis. For analysis of microscopy data nuclei were identiﬁed
usingDAPI co-staining. The nuclearMFI of EdU-Alexa488wasmeasured
and used for classiﬁcation of the proliferative activity (Fig. 2A and B).
After 16 h of incubation with LecB, the amount of proliferative active
cells was decreased from 93% to 69%, whereas co-incubation with
L-fucose prevented this effect (Fig. 2B). In FACS analysis, we were able
to identify clearly EdU-positive and -negative populations (Fig. 2C).
Again, EdU-positive cells decline from 98% to 88% upon LecB treatment
(Fig. 2D). The slight differences between the basic levels and differences
of EdU-positive cells in microscopy and FACS approaches are probably
due to varying procedures of staining and analysis. Interestingly, the
FACS data showed two peaks for EdU-positive cells, whereas only the
lower intensity peak was decreased upon LecB treatment. This suggests
that cells exhibit different susceptibility to LecB depending on the phase
of cell cycle. In order to test this hypothesis, we used a propidium iodide
(PI) staining to determine the phase of cell cycle by measuring cellular
DNA content. For quantiﬁcation, the Dean/Jett/Fox algorithm (FlowJo)
was used (Fig. 2E, left). Cells with less than diploid DNA content
(SubG1) represent apoptotic cells with degraded DNA andwere quanti-
ﬁed separately. LecB treatment resulted in a signiﬁcant decrease of
the fraction of S phase cells from 33% to 19% together with an increase
of cells with SubG1 DNA content from 1% to 6% (Fig. 2E, right and
Fig. 2F). In addition, a clear, but not signiﬁcant, increase of cells in G1
phase from 41% to 49% was observed. This may indicate a deregulation
of G1 to S phase transition, partially leading to DNA degradation, which
is typically followed by cell death. Again, co-incubation with L-fucose
prevented LecB-induced effects (Fig. 2C–F). In order to elucidate
whether the effects on proliferation are accompanied by induction of
apoptosis, a luminescent caspase assay was performed. The results
showed that activity of caspase 3 and 7 upon LecB treatment were sim-
ilar to the untreated negative control, whereas incubation with 1 μM
staurosporine signiﬁcantly increased caspase 3 and 7 activity by 2.5-
to 3-fold after 5 h and 16 h, respectively (Suppl. Fig. 1C). Thus, decreased
proliferation is not caused by induction of apoptosis during LecB
stimulation.
To exclude that the described effects are unique to H1299 cells, key
experiments were also performed in other cell lines. LecB inhibited
cell migration and induced NF-κB nuclear translocation to a comparable
extent in another lung epithelial cell line (H1975, Suppl. Fig. 2A–C). Fur-
thermore, the repressing effects of LecB on proliferative activity have
been also observed in the acute myeloid leukemia cell line THP-1 [34].
Taken together, our experiments demonstrate that soluble LecB is
sufﬁcient to strongly attenuate cell migration and proliferation and to
induce NF-κB signaling.
2.2. LecB induces proteasomal β-catenin degradation depending on
GSK-3β-activity
Since β-catenin is a key regulator of proliferation andmigratory pro-
cesses the total protein amount of β-catenin was estimated byWestern
blot analysis. LecB stimulation decreased β-catenin protein levels with-
in 60 min to 20% of the initial protein amount (Fig. 3A). For longer
Fig. 1. LecB attenuates migration and induces NF-κB nuclear translocation, transcriptional activity and TNF-α expression. (A) H1299 cells were grown to conﬂuence, scratched and
stimulated with LecB (0.09 μM to 4.3 μM) in the presence or absence of L-fucose (43 mM). Distances between the cell fronts were monitored after 8, 12 and 24 h. The absolute
migrated distance after different time periods as well as (B) the mean migration speed after indicated treatments is depicted. (C) Cells were treated as indicated and analyzed by
confocal ﬂuorescence microscopy with immunostaining for NF-κB-p65 (red) and counterstaining for DNA (DAPI, blue). White squares highlight areas that are further magniﬁed in the
right column. (D) Microscopy samples were prepared as described in (C) and nuclear location of p65 was quantiﬁed by estimating the nuclear mean ﬂuorescence intensity (MFI) of
p65. (E) Cells were transfected with NF-κB luciferase reporter plasmid and treated as indicated for 5 h. Luciferase activity was normalized to the protein concentration. (F) Cells were
treated as indicated and mRNA levels of TNF-α were estimated by qPCR, normalized to GAPDH mRNA levels and are presented in relation to the corresponding control. TNF-α
expression level after different time periods as well as (G) the expression after 24 h in the presence and absence of L-fucose is depicted. Except for (D) all values represent the mean of
at least three independent experiments ± SEM. For (D) median values of three independent experiments with lower and higher quartile are shown. Error bars represent 1.5
interquartile range (IQR) values. Asterisks in all graphs indicate the statistical signiﬁcance compared to the untreated control.
Fig. 2. LecB attenuates proliferation and reduces number of cells in the S-phase. All stimulations were performed with 4.3 μM LecB and 43 mM L-fucose. (A) Cells were treated with
indicated stimuli in the presence of EdU (10 μM) for 16 h and analyzed by confocal ﬂuorescence microscopy. EdU was linked to Alexa488 (green) and cells were counterstained with
DAPI (blue). Representative images as well as (B) quantiﬁcation of proliferative activity are depicted. The nuclear MFI of EdU was used as a measure for the proliferative activity.
(C) Cells were treated with indicated stimuli in the presence of EdU (10 μM) for 16 h. EdU was linked to Alexa647 and cells were analyzed by FACS. Representative histograms as well
as (D) quantiﬁcation of proliferative activity are shown. Cells above the threshold that is delineated in (C) as vertical line were regarded as proliferative active. (E) Cells were treated
with indicated stimuli for 16 h and stained for their DNA content with Propidium iodide (PI). Percentages of cells in each cell cycle phase were determined by Dean/Jett/Fox algorithm
(FlowJo). Representative histograms with algorithm (left), different stimuli (right) as well as (F) percentage of cells in each cycle phase are shown. As SubG1 cells are not considered
in Dean/Jett/Fox algorithm they were quantiﬁed separately by gating for cells with less DNA content than for G1 cells. All values represent the mean of at least three independent
experiments ± SEM. Asterisks indicate the statistical signiﬁcance compared to the untreated control.
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expression level, whereas addition of L-fucose prevented β-catenin re-
duction by inhibiting LecB binding to host cells (Fig. 3B). Comparable
LecB-mediated β-catenin degradation was also observed in H1975
(Suppl. Fig. 2D) and in THP-1 cells [34]. Degradation of β-catenin isinduced by GSK-3β-dependent phosphorylation, which is negatively
regulated by Akt through Ser9 phosphorylation. Since Akt activity has
been reported to be induced by P. aeruginosa [35] we assayed the acti-
vating phosphorylation of Akt (Ser473) and the inhibitory phosphoryla-
tion of GSK-3β (Ser9) in response to LecB treatment. Indeed, LecB was
1110 C. Cott et al. / Biochimica et Biophysica Acta 1863 (2016) 1106–1118able to induce Akt activation, as well as inhibitory phosphorylation of
GSK-3β (Fig. 3C). Interestingly, the kinetics of both phosphorylations
were different. Whereas Akt phosphorylation showed a peak after
60 min and reached control level after overnight incubations (16 h),
GSK-3β phosphorylation continuously increased until 5 h and remained
at high level during overnight experiments. The LecB-induced inhibito-
ry phosphorylation of GSK-3β would be expected to cause an accumu-
lation of β-catenin. However, our previous experiments (Fig. 3A)
showed that LecB stimulation resulted in β-catenin degradation. In
order to resolve this contradiction,we carried out experimentswith dif-
ferent inhibitors of Akt (and its upstreamkinase PI3K) andGSK-3βupon
stimulation with LecB. Since some of the inhibitors alone already
changed basic β-catenin levels, all LecB stimulation results were related
to the corresponding control containing only the inhibitor. As seen in
Fig. 3D, inhibition of PI3K and Akt signaling by LY294002 (LY: 100 μM)
and Akt inhibitors (triciribine, TCN: 10 μM and Akt1/2 inhibitor, Akti:
10 μM), respectively, did not inﬂuence the LecB-induced β-catenin deg-
radation indicating an independency from PI3K/Akt signaling. In con-
trast, an inhibition of GSK-3β activity using lithium chloride (LiCl:
20 mM) and TWS119 (TWS: 20 μM) partially blocked LecB-induced β-
catenin degradation by elevating the protein level from 10% to 50%
and 70% of the initial protein level, respectively (Fig. 3E). These experi-
ments argue for an importance of GSK-3β activity for LecB-induced β-
catenin degradation, whereas the inhibitory effect of Akt on GSK-3β
may be blocked or circumvented by LecB.
In addition,we applied inhibitors of proteasomal and lysosomal deg-
radation to elucidate the pathway of β-catenin depletion. Lysosomal in-
hibition by baﬁlomycin (Baf: 0.2 μM) had no effect on β-catenin
degradation, whereas proteasomal inhibition using lactacystin (Lact:
10 μM) increased the protein level from 40% to 70% (Fig. 3D). This
suggests that β-catenin is degraded by proteasomes during LecB
stimulation.
The cellular amount of β-catenin is regulated by an equilibrium be-
tween continuous de-novo synthesis and degradation of protein excess.
In order to elucidate whether suppression of de-novo protein synthesis
modulates LecB-induced β-catenin degradation, cells were co-
incubated with cycloheximide (Cyclo: 100 μg/ml), a protein synthesis
inhibitor. The presence of cycloheximide did not signiﬁcantly inﬂuence
LecB-induced β-catenin degradation after 3 h and 5 h of treatment
(Suppl. Fig. 3A and B). These data show that de-novo protein synthesis
only marginally inﬂuences cellular β-catenin levels during LecB
treatment. In summary, LecB induced proteasomal degradation of
β-catenin, which was independent from Akt signaling, whereas GSK-
3β activity was required to reach full degradation.
2.3. LecB stimulation reduces cell–cell contacts and promotes degradation
of β1-integrin
To elucidate if the membrane-bound pool of β-catenin is affected by
LecB, we followed the localization of β-catenin upon LecB stimulation
using confocal ﬂuorescence microscopy. We observed a reduction of
β-catenin staining at cell–cell contacts and an accumulation of β-
catenin close to nuclei after 3 to 5 h of LecB stimulation, indicating
that β-catenin was removed from the plasma membrane (Fig. 4A,
arrowheads). Since cytosolic proteasomes are mainly localized at cen-
trosome [36] samples were co-stained for γ-tubulin as centrosomalFig. 3. LecB induces proteasomal β-catenin degradation, which requires GSK-3β activity but is
43 mM L-fucose. All graphs present densitometric quantiﬁcation of protein levels performed
were normalized to actin or pan staining and actin, respectively. (A) H1299 cells were treated
were treated as indicated for 1 h and β-catenin protein level is depicted. (C) Cells were stimu
3β are shown. (D) Cells were stimulated for 2 h with LecB and inhibitors of the proteasome (l
(LY294002, LY, 100 μM) and Akt (triciribine, TCN, 10 μM; Akt1/2 inhibitor, Akti, 10 μM). Inh
inhibitors changed the basic levels of β-catenin, LecB samples are depicted in relation to c
inhibitors of GSK-3β (TWS119, TWS, 20 μM and lithium chloride, LiCl, 20 mM). Inhibitors wer
at least three independent experiments ± SEM. Asterisks indicate the statistical signiﬁcance comarker. We observed a clear accumulation of β-catenin around centro-
somes (Fig. 4B), which further supports the role of proteasomes in
β-catenin degradation.
Interestingly, Western blot experiments showed that LecB also in-
duces a reduction of the cell adhesion factor β1-integrin to 50% after
1 h, which remained at 30% afterwards (Fig. 5A and B). As depicted in
Fig. 5B, we observed a strong internalization of β1-integrin to the
same location as β-catenin after LecB treatment.
In summary, LecB reduces β-catenin at cell–cell adhesion sites
and induces an accumulation of the protein close to centrosomes,
where a high abundance of proteasomes is described [36]. In addition,
β1-integrin is internalized to the same location as β-catenin and also
degraded.
2.4. LecB acts antagonistically toWnt signaling and reduces protein levels of
Wnt targets
The cytosolic and the nuclear pool of β-cateninmediate its major ef-
fects onmigration, proliferation and inﬂammation. Thus, we also exam-
ined effects of LecB on the free, cytosolic pool of β-catenin. For this, we
co-stimulated the cells withWnt3a (400 ng/ml), a prototypical inducer
of β-catenin accumulation and its nuclear translocation. In immunoﬂu-
orescence experiments, Wnt3a-stimulated cells showed a higher cyto-
solic signal of β-catenin, as well as an increased nuclear translocation
compared to control cells (Fig. 6A). This accumulation of β-catenin
was also conﬁrmed in Western blot analysis, where the protein level
was continuously increased until a maximum of 3.5 fold induction
was achieved after 5 h (Fig. 6B). Again, LecB treatment reduced the β-
catenin protein level, as seen in immunoﬂuorescence experiments
(Fig. 6A) as well as in Western blot analyses (Fig. 6B). Interestingly,
co-incubation of Wnt3a and LecB completely prevented the Wnt3a-
induced accumulation and nuclear translocation of β-catenin, but also
slightly reduced the LecB-mediated loss of cell–cell contacts (Fig. 6A).
Furthermore, Western blot experiments showed that co-incubation
prevented β-catenin accumulation but also delayed β-catenin degrada-
tion (Fig. 6B). These results point to a crosstalk between Wnt3a and
LecB effects and suggest that LecB-induced β-catenin degradation is
alsomanipulating the cytosolic pool of the protein. Since this may inﬂu-
ence the transcriptional activity ofβ-catenin,we additionally performed
luciferase assays with the β-catenin-responsive reporter plasmid 7TFP
[37]. The assays showed a continuous decrease of transcriptional activ-
ity to around 50% after 5 h of LecB stimulation (Suppl. Fig. 3C). This re-
duction supports the hypothesis that the strong degradation of β-
catenin also negatively affects its transcriptional activity. In order to fur-
ther conﬁrm these ﬁndings, we directly analyzed the protein levels of
the β-catenin targets cyclin D1 and c-myc, which are also implicated
in the regulation of migration and proliferation. Indeed, the cyclin D1
protein level was signiﬁcantly decreased to 60% and 70% after 1 and
5 h and to 20% upon overnight incubation for 16 h (Fig. 6C). In contrast,
c-myc showed different kinetics with a signiﬁcant 1.4 fold elevation of
the protein level after 1 h of LecB stimulation, which was reduced
back to control levels after 3 and 5 h. However, c-myc levelswere ﬁnally
reduced to the same extent as cyclin D1 after overnight incubations
with LecB (Fig. 6C). The analysis of other cyclins showed that the protein
level of cyclin E2, whose expression directly depends on cyclin D1 accu-
mulation and interaction with corresponding Cdks [38], was alsoindependent from Akt signaling. All stimulations were performed with 4.3 μM LecB and
with ImageJ and corresponding representative blots. Protein and phosphorylation levels
as indicated for different time periods and β-catenin protein level is depicted. (B) Cells
lated as indicated for different time periods and phosphorylation levels of Akt and GSK-
actacystin, Lact, 10 μM), lysosomes/vacuolar H+-ATPase (baﬁlomycin, Baf, 100 μM), PI3K
ibitors were pre-incubated for 30 min at 37 °C and maintained during stimulation. As
ontrols containing only the inhibitor. (E) Cells were stimulated for 5 h with LecB and
e incubated and data are presented as described in (D). All values represent the mean of
mpared to control samples.
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clin B1, which is important during progression of M phase and is not di-
rectly inﬂuenced by cyclin D1, remained mainly unaffected (Suppl.Fig. 3D and E). During cell cycle the cyclin D1/Cdk4/6 complex can phos-
phorylate the Rb protein at Ser795 in order to inhibit its suppressive ef-
fect on transcription [39]. Interestingly, this phosphorylation was also
1112 C. Cott et al. / Biochimica et Biophysica Acta 1863 (2016) 1106–1118strongly reduced upon LecB treatment (Suppl. Fig. 3D and E). Further-
more, the pan staining of the Rb protein showed a shift to a slightly
lower molecular weight suggesting the loss of numerous modiﬁcations
of this temporarily highly phosphorylated protein. The LecB-induced
regulation of cyclin D1, cyclin E2 and Rb phosphorylation, which are
all proteins involved in G1–S-phase transition, is in accordance with
the data from Fig. 2E and F showing a reduction of cells in S-phase
upon LecB treatment.
Taken together, LecB is capable of repressing Wnt3a-induced
β-catenin accumulation and nuclear translocation. Furthermore, over-
night stimulation with LecB diminished protein levels of c-myc and cy-
clin D1, which are typical transcriptional targets of β-catenin. The
reduction of cyclin D1 also affected the protein level of cyclin E2 and
the phosphorylation state of the Rb protein.
3. Discussion
P. aeruginosa is a common opportunistic pathogen and causes acute
lung injury in ventilator-associated pneumonia [4]. Upon these infec-
tions, the tissue integrity is destroyed and a strong inﬂammation is gen-
erated [3]. The re-establishment of the tissue structure requires a
reduction of inﬂammation as well as an induction of cell proliferation
and migration [5]. P. aeruginosa is able to repress these mechanisms,
in order to facilitate bacterial dissemination into blood circulation,
which may lead to fatal sepsis [4].
In this study,we investigated the effects of the P. aeruginosa lectin LecB
on these repression mechanisms in a lung cell model and observed a
pronounced attenuation of host cell migration and proliferation together
with an induction of NF-κB-mediated signaling. According to these
results, we propose LecB as a player in P. aeruginosa-induced delay of
tissue repair. Furthermore, we observed a strong degradation of the cyto-
solic and themembrane pool of β-catenin during LecB stimulation, which
may represent the molecular basis for the inhibition of tissue recovery.
An antagonistic regulation between β-catenin and inﬂammation
during bacterial infection has already been described for P. aeruginosa
and S. typhimurium [24,27]. However, the responsible bacterial factors
were not identiﬁed. In particular, in a murine P. aeruginosa keratitis
model it was shown that the bacterium induces β-catenin degradation
and a strong inﬂammation, leading to enduring tissue destruction
even after complete bacterial clearance [27]. In addition, a prevention
of β-catenin degradation by transfecting a non-degradable mutant di-
minished the induction of inﬂammation. Interestingly, the induced in-
ﬂammatory genes were TNF-α, IL-6 and IL-1β, which are all under the
control of NF-κB. In accordance, mice challenged with S. typhimurium
showed β-catenin degradation in intestine samples, which was accom-
panied by an induction of NF-κB activity [24]. Again, a stabilization of
β-catenin decreased the inﬂammatory induction during infection.
Both studies support our hypothesis that the loss of β-catenin during
LecB stimulation can induce the activation of NF-κB signaling (Figs. 1
and 3). An induction of NF-κB activity through β-catenin degradation
could also explain the late onset of LecB-mediated effects on NF-κB as
compared to the immediate NF-κB activation by other molecules like
TNF-α. Furthermore, fucose-binding lectins from other lung pathogens,
like Burkholderia cenocepacia and Aspergillus fumigatus, which are
not related in sequence to LecB, were also described to display pro-
inﬂammatory effects [40,41].
For the effects of LecB on cell migration β-catenin degradation may
be a suitable explanation as well. Migration is a precise and dynamic
interplay between a variety of processes, including cell–matrix attach-
ment and detachment, cell–cell adhesion, cell polarity as well as cyto-
skeletal rearrangement [42]. Several studies identiﬁed GSK-3β as key
regulator of migration, whereas its exact effect was dependent on the
cellular model system. In particular, it was described that inhibition of
GSK-3β directly reduces formation of extended lamellipodia andmigra-
tion of keratinocytes, which supports a promoting effect of GSK-3β on
cell migration [43]. In contrast, Karrasch et al. described an activationof Akt signaling with following inhibitory phosphorylation of GSK-3β,
leading to increased transcriptional activity of β-catenin and by this en-
hancedmigration of intestinal epithelial cells [44]. Interestingly, we also
observed Akt activation and inhibitory GSK-3β phosphorylation, but
without the following increase in β-catenin protein level and migration
(Fig. 3). Therefore, it is possible that the P. aeruginosa lectin LecB induces
parallel pathways in order to evade the induction of migration, which
can facilitate the establishment and stabilization of bacterial infection.
In support of this, it was proposed that, depending on the interaction
partner of GSK-3β, a β-catenin binding and phosphorylation is structur-
ally possible, even if the inhibitory phosphorylation ofGSK-3β is present
[45]. Furthermore, it was hypothesized that GSK-3β phosphorylation is
prevented if the protein is bound to Axin within the destruction
complex [46].
Also integrins were reported to play a crucial role in cell migration
[47]. For instance, β1-integrin was described to stabilize the primary
lamellipodia and by this promoting migration in a complex with α3-
integrin [48]. Besides the main localization at cell–matrix contacts,
α3β1-integrins were also found to stimulate and localize to cadherin-
catenin complexes together with tetraspanin CD151 [19]. CD151 itself
was reported to suppress cell migration, when it is released from
integrins [49]. Hence, the described depletion of β1-integrin (Fig. 5)
and its removal from cell–cell and cell–matrix contacts, may contribute
to decreased migration.
Cell proliferation constitutes a central mechanism in cell mainte-
nance, tissue homeostasis and repair. Our observation of fewer cells in
S phase andmore cells in the G1 and SubG1 population upon LecB stim-
ulation indicate a normal cell cycle progression of S phase cells, but a
lack of new cells entering this phase (Fig. 2). This effect argues for an ar-
rest at the G1-S transition point. As cyclin D1 is a central inducer of this
transition, the observed down-regulation of this and other related pro-
teins like cyclin E2 and Rb supports the hypothesis of a G1-S phase ar-
rest upon LecB treatment, which leads to attenuated proliferation and
minor cell death (SubG1) (Figs. 2 and 6, Suppl. Fig. 3). Indeed, several
studies showed that a downregulation ofβ-catenin by upstream regula-
tors or shRNA decreases cyclin D1 expression [50,51], which supports
the hypothesis that β-catenin depletion directly contributes to reduced
proliferation.
We propose that LecB may contribute to ALI and can work together
with other P. aeruginosa cytotoxins, like ExoU, ExoT and LepA, which
may also play roles in ALI and inﬂammation [52–54]. Our hypothesis
of an impact of LecB on ALI is further supported by a study, which de-
scribes a decrease in bacterial burden and dissemination in an in vivo
murine model of ALI during infections with a LecB-deﬁcient mutant or
LecB-inhibition with speciﬁc glycoconjugates [14,15]. In accordance, it
was shown that LecB and other bacterial lectins can efﬁciently be
blocked by synthetic glycoconjugates [14,55–57].
Our study not only broadens the knowledge how the catalytically in-
active lectin LecB severely changes host cell signaling and may contrib-
ute to pathogenicity, but also provides additional rationale for using
synthetic LecB-binding glycoconjugates for alternative therapies of
P. aeruginosa infections.
4. Materials and methods
4.1. Cell cultivation, stimulation and inhibitors
H1299 and H1975 lung epithelial cells were grown at 37 °C and 5%
CO2 in RPMI-1640 (Gibco) with 10% FCS and 2mM L-glutamine (Gibco).
Lyophilized, recombinant LecB (Dr. Anne Imberty) was dissolved in
PBS (with Ca/Mg) and used at concentrations of 0.09 μM, 0.9 μM and
4.3 μM for indicated time periods. Starvation in serum-free medium
was performed, when indicated, for 2 h before treatment and main-
tained during stimulation. In order to block fucose-binding sites of
LecB, L-fucose (Sigma-Aldrich)was directly dissolved inmedium, sterile
ﬁltered and used at a ﬁnal concentration of 43 mM for the same time
Fig. 4. LecB reduces cell–cell contacts and β-catenin locates to the centrosome. All experiments were performedwith 4.3 μMLecB. (A) Cells were stimulated as indicated for different time
periods and analyzed by confocal ﬂuorescence microscopy with immunostaining for β-catenin (red) and counterstaining for DNA (DAPI, blue). Arrowheads highlight the perinuclear
accumulation of β-catenin. (B) Cells were treated as indicated for 3 h and analyzed by confocal ﬂuorescence microscopy with immunostainings for γ-tubulin (green), β-catenin (red)
and counterstaining for DNA (DAPI, blue). In order to visualize centrosomes of multiple focal planes, maximum intensity projections of 4 Z-stacks are depicted. White squares
highlight areas that are further magniﬁed in the right column. Arrowheads highlight the localization of centrosomes.
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the following concentrations: Wnt3a (400 ng/ml, R&D Systems), TNF-
α (10 ng/ml, Life Technologies) and staurosporine (Stauro, 1 μM,
Sigma-Aldrich). The used inhibitors were pre-incubated for 30 min at
37 °C and maintained during stimulation at following concentrations:lactacystin (Lact, 10 μM, Biomol), baﬁlomycin (Baf, 0.2 μM, Invivogen),
LY294002 (LY, 100 μM, Sigma-Aldrich), triciribine (TCN, 10 μM,
Sigma-Aldrich), Akt1/2 inhibitor (Akti, 10 μM, Sigma-Aldrich),
TWS119 (TWS, 20 μM, Selleckchem), lithium chloride (LiCl, 20 mM,
Roth) and cycloheximide (Cyclo, 100 μg/ml, Sigma-Aldrich).
Fig. 5. Beta1-integrin is degraded and locates to the perinuclear region. All treatments were performedwith 4.3 μMLecB. (A) Cells were treated as indicated for different time periods and
β1-integrin protein levels were determined byWestern blot analysis and densitometric quantiﬁcation using ImageJ. Protein levels were normalized to actin. Representative blots (above)
and quantiﬁcation data (below) are depicted. Values represent the mean of at least three independent experiments ± SEM. Asterisks indicate the statistical signiﬁcance. (B) Cells were
treated as indicated for 1 h and 5 h and analyzed by confocal ﬂuorescence microscopy with immunostainings for β-catenin (green), β1-integrin (red) and counterstaining for DNA
(DAPI, blue).
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H1299 or H1975 cells were grown to conﬂuence and scraped using a
sterile pipet tip. Same positions of cell gaps with an approximate width
of 500 μmwere monitored using EVOS microscope (peqlab) after indi-
cated time points. To minimize the effects of proliferation during this
assay, it was performed under serum starvation. Distances between
both cell fronts were measured using the vector graphic software
Inkscape (Open Source, version 0.48).
4.3. PI cell cycle test
Cells were grown to 50% conﬂuence and stimulated as indicated for
16 h. For staining, cells were trypsinized, nuclei were isolated and
stained with the Cycletest™ Plus DNA Reagent Kit (BD Biosciences) ac-
cording to the manufacturer's instructions. The PI ﬂuorescence of the
nuclei was measured using the Beckman Coulter Gallios™ Flow
Cytometer. Analysis was performed with FlowJo software (version X
10.0.7r2). Dot plots displaying peak versus area values of forward scatter
(FS) and sideward scatter (SS) were used to gate for single nuclei in
order to exclude aggregates from analysis. Subsets of G1, S and G2
phase were estimated by Dean/Jett/Fox algorithm of FlowJo software.
Not considered SubG1 subsets were assessed separately by gating for
cells with less DNA content than for G1. Per experiment and condition
20.000 events were measured.
4.4. EdU proliferation assay
For investigating EdU incorporation, Click-iT® EdU assays (Life
Technologies) for imaging and ﬂow cytometry were used.
For microscopy experiments cells were seeded on glass coverslips,
grown to 50% conﬂuence and were incubated in the presence of
10 μM EdU and the distinct stimulus for 16 h. Afterwards, cells were
trypsinized, ﬁxed with 4% paraformaldehyde (PFA), stained according
to the manufacturer's instruction and additionally counterstained withDAPI (1 μg/ml, Roth). Fluorescence images were recorded with a
Nikon confocal laser scanning microscope as described below. Analysis
was done using Nikon NIS analysis software (NIS-Elements 4.20). Re-
gions of interest (ROIs)were identiﬁed corresponding to theDAPI signal
and subsequently analyzed for mean ﬂuorescence intensity (MFI) of
EdU-Alexa488. The nuclear MFI of EdU-Alexa488 was measured and
normalized by the DAPI signal. Cells with a Alexa488/DAPI ratio above
a threshold, which was determined from the cumulative distribution
function of all values, were classiﬁed as proliferative active. Per experi-
ment and condition, at least 200 cells were analyzed.
For FACS analysis cells were seeded to 50% conﬂuence and incubated
with EdU (10 μM) and the corresponding stimulus for 16 h. Afterwards,
cells were trypsinized, ﬁxed with 4% PFA and stained following the
manufacturer's instruction. Flow cytometry and analysiswas performed
using Beckman Coulter Gallios™ Cytometer and FlowJo software
(version X 10.0.7r2), respectively. Dot plots displaying peak versus
area values of FS and SS were used to gate for single cells in order to ex-
clude doublets from analysis. For quantiﬁcation cells above a threshold
(shown in Fig. 2C)were classiﬁed as proliferative active. Per experiment
and condition 20,000 events were measured.
4.5. Apoptosis assay
For analysis of apoptosis the Caspase-Glo 3/7 assay (Promega) was
used following manufacturer's instruction. Brieﬂy, 2.5 ∗ 104 H1299
cells were seeded into a well of a 96 well plate and grown over night.
The next day cells were either incubated with staurosporine, LecB or
left untreated for 5 and 16 h. Afterwards, supernatant was removed
and 100 μl Caspase Glow reagent per well was added. Subsequently
the plate was vortexed at 300 rpm for 30 s and incubated for 1.5 h at
room temperature. Luminescencewas detectedwith amicro plate read-
er (SynergyH4 Hybrid Reader, BioTek). Blank-corrected luminescence
values were normalized to values of untreated, control cells. Statistical
signiﬁcance was assessed by one-way analysis of variance (ANOVA)
followed by Dunnett's post-test.
Fig. 6. LecB antagonizesWnt3a-inducedβ-catenin nuclear translocation and reduces protein levels of cyclinD1 and c-myc. All treatmentswere performedwith 4.3 μMLecB and 400 ng/ml
Wnt3a. (A) Cells were treated as indicated for different time periods and analyzed by confocal ﬂuorescence microscopy with immunostaining for β-catenin (red) and staining of DNA
(DAPI, blue). (B) and (C) Cells were stimulated as indicated for different time periods and protein levels of β-catenin and cyclin D1/c-myc, respectively, were determined by Western
blot analysis and densitometric quantiﬁcation using ImageJ. Protein levels were normalized to actin. Representative blots (right) and quantiﬁcation data (left) are depicted. All values
represent the mean of at least three independent experiments ± SEM. Asterisks indicate the statistical signiﬁcance compared to the untreated control.
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Cells were seeded to 90% conﬂuence, starved for 2 h and stimulated
as indicated for different time periods. Starvation was performed to ex-
clude possible effects of growth factors and cytokines of serum, which
may interfere with LecB effects. For better comparability, experiments
described below were also performed under starving conditions. After-
wards, cells were lysed in Ripa buffer containing protease and phospha-
tase inhibitors (0.8 μM aprotinin, 11 μM leupeptin, 200 μM pefablock,1 mM sodium orthovanadate, 1% (v/v) phosphatase inhibitor cocktail
3, all compounds were purchased from Sigma-Aldrich) for 30 min at
4 °C and centrifuged to remove cell debris. Determination of protein
concentration was performed using BCA assay (Pierce) according to
the manufacturer's protocol. Equal amounts of protein were separated
on 8% polyacrylamide gels and transferred on nitrocellulose mem-
branes. Blots were blocked in 3% BSA and incubated with primary anti-
bodies at 4 °C overnight. Next day, blots were incubated with HRP-
conjugated secondary antibodies. Luminescence was detected using
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bodies were used for Western blots in this study: anti-β-catenin
(Abcam, #ab32572), anti-β-actin (Sigma, #A5316), anti-pAkt (Ser473)
(CST, #4060), anti-Akt (pan) (CST, #A4691), anti-pGSK-3β (Ser9)
(CST, #5558), anti-GSK (pan) (CST, #9315), anti-β1-integrin (Millipore,
#MAB2000), anti-p65 pSer536 (CST, #3033), anti-p65 pSer 468 (CST,
#3039), anti-cyclin E2 (CST, #4132), anti-cyclin B1 (CST, #12,231),
anti-Rb pan (CST, #9309), anti-Rb pSer795 (CST, #9301), anti-rabbit-
HRP (CST, #7074), anti-mouse-HRP (CST, #7076). Densitometric quan-
tiﬁcation of blots was performed using ImageJ (1.45b). Protein and
phosphorylation levels were normalized to actin or corresponding pan
staining and actin, respectively. As exception, Rb pSer795 signals were
normalized to actin, in order to avoid a bias from the quantiﬁcation of
shifted Rb pan bands.
4.7. NF-κB reporter assay
To evaluate the transcriptional activity of NF-κB, a luciferase reporter
assay was performed with the p1242 3×-KB-L plasmid (gift from Bill
Sugden, Addgene #26699) containing three MHC I KB elements [33].
For this, cells were grown to 70% conﬂuence and transfected with
the mentioned plasmid with polyethyleneimine (PEI, Polysciences) as
described elsewhere [58]. After 24 h cells were starved for 2 h and stim-
ulated for 5 h with indicated stimuli. In the following, cells were lysed
for at least 10 min in luciferase buffer (25 mM Tris–HCl pH 7.8,
15 mM MgSO4, 4 mM EGTA, 1% Triton X-100, 1 mM DTT). Lysates
were transferred into a white plate and ﬁreﬂy luciferase-substrate
(20 mM tricine, 2.67 mMMgSO4, 0.1 mM EDTA, 33.3 mM DTT, 524 μM
ATP, 218 μg/ml Acetyl-CoA, 131 μg/ml Luciferin, 5 mM NaOH, 264 μM
MgCO3) was added and luminescence was measured every 2 min for
30 min using the microplate reader Tecan Inﬁnite 200Pro. The three
highest values were used for quantiﬁcation and normalized to the pro-
tein concentration of the lysates. At least three independent experi-
ments were performed with three replicates per experiment and
condition.
4.8. Beta-catenin reporter assay
To evaluate the transcriptional activity of β-catenin, a luciferase re-
porter assay was performed with the plasmid 7TFP (gift from Roel
Nusse, Addgene #24,308 [37]). For the assay H1299 cells were seeded
in 24 well plates (1 ∗ 105 cells per well) and grown for 24 h. Then,
cells were transfected with the 7TFP plasmid and a plasmid encoding
Renilla luciferase under control of a CMV promoter (gift fromWilfried
Weber, University of Freiburg, Germany) using Lipofectamine 2000
(Thermo Fisher) for 12 h. After treatment with LecB for indicated time
periods, cells were lysed with luciferase buffer, and two aliquots of
each lysate were loaded on a white 96 well plate. One aliquot was sup-
plemented with ﬁreﬂy luciferase substrate; the other aliquot was sup-
plemented with Renilla luciferase substrate. The luminescence was
measured with a plate reader as described before. For quantiﬁcation,
the ﬁreﬂy luciferase readings were normalized to the Renilla luciferase
readings for each sample. Three independent experiments were per-
formed with three replicates per experiment and condition.
4.9. Quantitative RT-PCR
Cells were seeded to 90% conﬂuence, starved for 2 h and stimulated
for indicated time periods. Cellswere starved to estimate results that are
comparable to Western blot experiments. Afterwards, cells were lysed
with TRIzol (Sigma-Aldrich) and RNA was extracted following the
manufacturer's instructions. 1 μg RNA was transcribed into cDNA after
DNase digest using First Strand cDNA synthesis Kit with dsDNase (Ther-
mo Scientiﬁc). For qPCR itself SYBR Select qPCR Kit (Applied Biosystems,
Life Technologies)was used as recommended by themanufacturerwith
the following primers at a concentration of 10 μM: TNF-α (fwd: CTTCTCCTTCCTGATCGTGG, rev: GCTGGTTATCTCTCAGCTCCA), GAPDH (fwd:
CCTCCAAAATCAAGTGGGGCGAT, rev: CAAATGAGCCCCAGCCTTCTCC).
Samplesweremeasuredwith Biorad CFX384qPCR system and analyzed
using the BioRad Analysis software (version 3.0). Relative mRNA levels
of TNF-αwere normalized to GAPDH levels.
4.10. Immunoﬂuorescence, confocal microscopy and image analysis
Cells were grown on glass coverslips to 60% conﬂuence, starved for
2 h and stimulated for indicated time periods at 37 °C. Starvation was
performed to estimate results that are comparable to Western blot ex-
periments. After ﬁxation with 4% and saturation with 50 mM NH4Cl,
cells were permeabilized in blocking buffer containing 5% BSA, 0.3% Tri-
ton X-100 in PBS for 1 h at RT. Primary antibodies were incubated over-
night at 4 °C in a humidity chamber, secondary antibodies for 1 h at RT
and ﬁnally cells were counterstained with DAPI (1 μg/ml) andmounted
with Mowiol containing DABCO (Roth, antioxidant). As only exception,
samples for γ-tubulin staining were ﬁxed and permeabilized with ace-
tone/methanol (1:1) at−20 °C and processed as described above with
1 h incubation in blocking buffer. Following antibodies were used for
immunoﬂuorescence staining in this study: anti-β-catenin (Abcam,
#ab32572), anti-β1-integrin (Millipore, #MAB2000), NF-κB-p65 (CST,
#8242), anti-γ-tubulin (Sigma-Aldrich, #T5192), anti-rabbit-Cy3
(Jackson ImmunoResearch, #711-166-152), anti-rabbit-Alexa488
(Invitrogen, #A21206) and anti-mouse-Alexa647 (Invitrogen, #21,236).
For confocal microscopy the Nikon Eclipse Ti-E inverted microscope
equipped with a Nikon A1R confocal laser scanning system was used.
EdU assays were imaged with a 20× multi-immersion objective
(NA = 0.75, used with oil), NF-κB images with a 40× air objective
(NA = 0.6) and all remaining experiments with a 60× oil immersion
objective (NA = 1.49). Nuclear MFI of EdU was quantiﬁed with NIS-
Elements software (Nikon, version 4.20), whereas nuclear localization
of NF-κB was analyzed with ImageJ (1.45b). In both cases DAPI signal
was used to determine nuclear regions and the corresponding MFI
values were measured within these regions of interest.
4.11. Statistical analysis
Statistical analysis was performed with GraphPad Prism software
(version 5.04). All data (except NF-κB nuclear translocation, Fig. 1D,
Suppl. Fig. 2D) are presented as mean ± standard error of the mean
(SEM) values that have been calculated from the results of independent
experiments. Statistical signiﬁcance compared to the untreated control
was assessed by one-way analysis of variance (ANOVA) followed by
Dunnett's post-hoc test. Data from NF-κB nuclear translocation origin
from three independent experiments (Fig. 1D and Suppl. Fig. 2D). As
the values were not normally distributed, data are presented as boxplot
with median and the upper and lower quartile, whereas whiskers indi-
cate 1.5 interquartile range (IQR) values. Statistical signiﬁcance was
assessed by Kruskal–Wallis test with Dunn's post-hoc test. All results
are considered as statistically signiﬁcant with a p-value lower than
0.05. Asterisks indicate signiﬁcance levels in ﬁgures with NS =
p ≥ 0.05, * = p ≤ 0.05, ** = p ≤ 0.01 and *** = p ≤ 0.001.
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